XML 114 R101.htm IDEA: XBRL DOCUMENT v3.20.1
Other Intangible Assets - Currently marketed products acquired from Talecris and Progenika (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Other Intangible Assets    
Intangible assets at beginning of the year € 1,385,537 € 1,269,342
Translation differences 27,116 58,744
Intangible assets at end of the year 1,433,534 1,385,537
Gross carrying amount    
Other Intangible Assets    
Intangible assets at beginning of the year 2,054,740 1,841,207
Translation differences 36,634 80,172
Intangible assets at end of the year 2,195,126 2,054,740
Accumulated depreciation and amortisation    
Other Intangible Assets    
Intangible assets at beginning of the year (602,868) (508,485)
Additions (81,890) (71,400)
Translation differences (8,209) (18,473)
Intangible assets at end of the year (693,948) (602,868)
Currently marketed products    
Other Intangible Assets    
Intangible assets at beginning of the year 793,032 793,308
Additions (38,040) (36,154)
Translation differences 15,723 35,878
Intangible assets at end of the year 770,715 793,032
Currently marketed products | Gross carrying amount    
Other Intangible Assets    
Intangible assets at beginning of the year 1,071,827 1,024,376
Translation differences 21,007 47,451
Intangible assets at end of the year 1,092,834 1,071,827
Currently marketed products | Accumulated depreciation and amortisation    
Other Intangible Assets    
Intangible assets at beginning of the year (278,795) (231,068)
Additions (38,040) (36,154)
Translation differences (5,284) (11,573)
Intangible assets at end of the year € (322,119) € (278,795)
Talecris | Currently marketed products    
Other Intangible Assets    
Estimated useful life 30 years 30 years
Residual useful life 21 years 5 months 22 years 5 months
Talecris | Currently marketed products | Gross carrying amount    
Other Intangible Assets    
Intangible assets at beginning of the year € 1,048,035 € 1,000,584
Translation differences 21,007 47,451
Intangible assets at end of the year 1,069,042 1,048,035
Talecris | Currently marketed products | Accumulated depreciation and amortisation    
Other Intangible Assets    
Intangible assets at beginning of the year (264,920) (219,572)
Additions (35,661) (33,775)
Translation differences (5,284) (11,573)
Intangible assets at end of the year € (305,865) € (264,920)
Progenika Biopharma, S.A. | Currently marketed products    
Other Intangible Assets    
Estimated useful life 10 years 10 years
Residual useful life 3 years 2 months 4 years 2 months
Progenika Biopharma, S.A. | Currently marketed products | Gross carrying amount    
Other Intangible Assets    
Intangible assets at beginning of the year € 23,792 € 23,792
Intangible assets at end of the year 23,792 23,792
Progenika Biopharma, S.A. | Currently marketed products | Accumulated depreciation and amortisation    
Other Intangible Assets    
Intangible assets at beginning of the year (13,875) (11,496)
Additions (2,379) (2,379)
Intangible assets at end of the year € (16,254) € (13,875)